SMTL ID : 8sx4.1 (1 other biounit)

Crystal Structure of eIF4e in complex with Compound 7n

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x WXL: [(~{Z})-4-[2-azanyl-7-[(5-chloranyl-1~{H}-indol-2-yl)methyl]-6-oxidanylidene-1~{H}-purin-9-yl]but-2-enyl]phosphonic acid(Non-covalent)

WXL.1: 15 residues within 4Å: Chain A: W.20, F.21, F.22, W.30, L.34, D.64, S.66, P.74, M.75, W.76, E.77, V.127, N.129, R.131, W.140 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.22, A:D.64, A:P.74, A:V.127, A:W.140 Hydrogen bonds: A:W.76, A:R.131 Salt bridges: A:E.77 pi-Stacking: A:W.30, A:W.30, A:W.30, A:W.30, A:W.76, A:W.76 pi-Cation interactions: A:W.30, A:W.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cardenas, E.L. et al., Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer. J.Med.Chem. (2023)

Release Date

2023-06-21

Peptides

Eukaryotic translation initiation factor 4E: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Eukaryotic translation initiation factor 4E

Related Entries With Identical Sequence